These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 9434313)

  • 1. Anti-inflammatory cytokine levels in patients with septic shock.
    Kasai T; Inada K; Takakuwa T; Yamada Y; Inoue Y; Shimamura T; Taniguchi S; Sato S; Wakabayashi G; Endo S
    Res Commun Mol Pathol Pharmacol; 1997 Oct; 98(1):34-42. PubMed ID: 9434313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma levels of interleukin-1 receptor antagonist (IL-1ra) and severity of illness in patients with burns.
    Endo S; Inada K; Yamada Y; Kasai T; Takakuwa T; Nakae H; Kamei Y; Shimamura T; Suzuki T; Taniguchi S; Yoshida M
    J Med; 1996; 27(1-2):57-71. PubMed ID: 8863178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma and urinary cytokine homeostasis and renal function during cardiac surgery without cardiopulmonary bypass.
    Gormley SM; McBride WT; Armstrong MA; McClean E; MacGowan SW; Campalani G; McMurray TJ
    Cytokine; 2002 Jan; 17(2):61-5. PubMed ID: 11886172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation between pro- and anti-inflammatory cytokines and the production of nitric oxide (NO) in severe sepsis.
    Groeneveld PH; Kwappenberg KM; Langermans JA; Nibbering PH; Curtis L
    Cytokine; 1997 Feb; 9(2):138-42. PubMed ID: 9071565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two types of septic shock classified by the plasma levels of cytokines and endotoxin.
    Endo S; Inada K; Inoue Y; Kuwata Y; Suzuki M; Yamashita H; Hoshi S; Yoshida M
    Circ Shock; 1992 Dec; 38(4):264-74. PubMed ID: 1292890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of pro- and anti-inflammatory cytokines and the production of nitric oxide in patients receiving high-dose immunotherapy with interleukin-2.
    Locker GJ; Kofler J; Stoiser B; Wilfing A; Wenzel C; Wögerbauer M; Steger GG; Zielinski CC; Mader R; Burgmann H
    Eur Cytokine Netw; 2000 Sep; 11(3):391-6. PubMed ID: 11022123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-1 receptor antagonist, soluble tumor necrosis factor-alpha receptor type I and II, and soluble E-selectin serum levels in multiple sclerosis patients receiving weekly intramuscular injections of interferon-beta1a.
    Perini P; Tiberio M; Sivieri S; Facchinetti A; Biasi G; Gallo P
    Eur Cytokine Netw; 2000 Mar; 11(1):81-6. PubMed ID: 10705303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated serum levels of the type I and type II receptors for tumor necrosis factor-alpha as predictive factors for ARF in patients with septic shock.
    Iglesias J; Marik PE; Levine JS;
    Am J Kidney Dis; 2003 Jan; 41(1):62-75. PubMed ID: 12500222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increase of anti-inflammatory cytokines in patients with esophageal cancer after perioperative treatment with G-CSF.
    Hübel K; Mansmann G; Schäfer H; Oberhäuser F; Diehl V; Engert A
    Cytokine; 2000 Dec; 12(12):1797-800. PubMed ID: 11097751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in the profiles of circulating levels of soluble tumor necrosis factor receptors and interleukin 1 receptor antagonist reflect the heterogeneity of the subgroups of juvenile rheumatoid arthritis.
    Muzaffer MA; Dayer JM; Feldman BM; Pruzanski W; Roux-Lombard P; Schneider R; Laxer RM; Silverman ED
    J Rheumatol; 2002 May; 29(5):1071-8. PubMed ID: 12022325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistently elevated soluble tumor necrosis factor receptor and interleukin-1 receptor antagonist levels in critically ill patients.
    Rogy MA; Coyle SM; Oldenburg HS; Rock CS; Barie PS; Van Zee KJ; Smith CG; Moldawer LL; Lowry SF
    J Am Coll Surg; 1994 Feb; 178(2):132-8. PubMed ID: 8173722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional modification of vascular endothelial cells by cytokines during septic shock.
    Endo S; Inada K; Yamada Y; Takakuwa T; Nakae H; Kasai T; Koike S; Inoue Y; Niimi M; Wakabayashi G; Taniguchi S
    Res Commun Mol Pathol Pharmacol; 1996 Oct; 94(1):23-38. PubMed ID: 8948012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin 13 and inflammatory markers in human sepsis.
    Collighan N; Giannoudis PV; Kourgeraki O; Perry SL; Guillou PJ; Bellamy MC
    Br J Surg; 2004 Jun; 91(6):762-8. PubMed ID: 15164448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activity.
    Gabay C; Cakir N; Moral F; Roux-Lombard P; Meyer O; Dayer JM; Vischer T; Yazici H; Guerne PA
    J Rheumatol; 1997 Feb; 24(2):303-8. PubMed ID: 9034987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early postoperative compensatory anti-inflammatory response syndrome is associated with septic complications after major surgical trauma in patients with cancer.
    Mokart D; Capo C; Blache JL; Delpero JR; Houvenaeghel G; Martin C; Mege JL
    Br J Surg; 2002 Nov; 89(11):1450-6. PubMed ID: 12390391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proinflammatory cytokine inhibitors, TNF-alpha and oxidative burst of polymorphonuclear leukocytes in the pathogenesis of sepsis in newborns.
    Sikora JP; Chlebna-Sokół D; Dabrowska I; Lipczyński D; Chrul S
    Arch Immunol Ther Exp (Warsz); 2001; 49(2):155-61. PubMed ID: 11348020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble cytokine receptors sTNFR I and sTNFR II, receptor antagonist IL-1ra, and anti-inflammatory cytokines IL-10 and IL-13 in the pathogenesis of systemic inflammatory response syndrome in the course of burns in children.
    Sikora JP; Kuzański W; Andrzejewska E
    Med Sci Monit; 2009 Jan; 15(1):CR26-31. PubMed ID: 19114968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitrite/nitrate oxide (NOx) and cytokine levels in patients with septic shock.
    Endo S; Inada K; Nakae H; Arakawa N; Takakuwa T; Yamada Y; Shimamura T; Suzuki T; Taniguchi S; Yoshida M
    Res Commun Mol Pathol Pharmacol; 1996 Mar; 91(3):347-56. PubMed ID: 8829774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor-alpha is not essential in endotoxin induced eye inflammation: studies in cytokine receptor deficient mice.
    Rosenbaum JT; Han YB; Park JM; Kennedy M; Planck SR
    J Rheumatol; 1998 Dec; 25(12):2408-16. PubMed ID: 9858438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pretreatment cytokine profiles of peripheral blood mononuclear cells and serum from patients with rheumatoid arthritis in different american college of rheumatology response groups to methotrexate.
    Seitz M; Zwicker M; Villiger PM
    J Rheumatol; 2003 Jan; 30(1):28-35. PubMed ID: 12508386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.